Want to join the conversation?
$MYL announced U.S. launch of Dutasteride Capsules, 0.5 mg, generic version of $GSK's Avodart Capsules. Mylan received final FDA approval for this product, which is indicated as monotherapy for treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostate to improve symptoms, reduce risk of acute urinary retention.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.